Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128844) titled 'Study on the Efficacy and EEG Characteristics of Dexmedetomidine Combined with Esketamine in the Treatment of Adolescent Major Depressive Disorder' on July 27.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Guabgzhou First People's Hospital

Condition: Major Depressive Disorder in Adolescents

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-08-01

Target Sample Size: Therapy Group:60;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=333939

Disclaimer: Curated by HT Syndication....